## Labetalol: A Unique Combined Alpha-Beta Blocker **Key Point:** Labetalol is a non-selective beta blocker with concurrent alpha-1 adrenergic blocking activity, making it a combined alpha-beta antagonist. The ratio of beta to alpha blocking is approximately 7:1 to 3:1 depending on the route of administration. ### Mechanism and Pharmacology 1. **Beta-blocking effect** (predominant): Non-selective antagonism at β₁ and β₂ receptors 2. **Alpha-1 blocking effect** (secondary): Antagonism at α₁-adrenergic receptors on vascular smooth muscle 3. **Net result**: Reduction in peripheral vascular resistance without reflex tachycardia (alpha blockade prevents compensatory sympathetic activation) ### Clinical Advantages of Dual Action | Feature | Benefit | | --- | --- | | **Vasodilation** | Reduces afterload; useful in hypertensive emergencies | | **No reflex tachycardia** | Alpha blockade prevents compensatory HR increase | | **Blood pressure control** | Superior to pure beta blockers in some hypertensive states | | **Pregnancy safety** | First-line agent for hypertension in pregnancy (methyldopa is alternative) | **High-Yield:** Labetalol is the drug of choice for hypertensive emergencies in pregnancy and perioperative hypertension because it reduces BP without causing fetal hypoperfusion (unlike pure vasodilators) and avoids reflex tachycardia. **Clinical Pearl:** The alpha-blocking effect is weak enough that orthostatic hypotension is uncommon, yet strong enough to prevent the reflex tachycardia seen with pure beta blockers — a unique advantage in acute hypertension management. **Mnemonic:** **LABE** = **L**abetalol has **A**lpha **BE**ta activity.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.